Lamotrigine Open Trial in Refractory Epilepsy
Abstract
Lamotrigine, 5 and 15 mg/kg/daily, was administered as add-on therapy in 37 outpatient children and adolescents with refractory epilepsy and mental delay treated at the Child Neuropsychiatry Unit, Department of Pediatrics, Second University of Naples, Italy.
DOI: https://doi.org/10.15844/pedneurbriefs-11-10-13 | Journal eISSN: 2166-6482
Language: English
Page range: 79 - 80
Published on: Oct 1, 1997
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
© 1997 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.